- Friday 1st of October 2021
Are Super Vilitra Tablets Suitable For Men With Low Sperm Count?
Super Vilitra is a prescription medication used to treat erectile dysfunction (ED) and premature ejaculation (PE). It typically contains vardenafil, which improves blood flow to the penis, and dapoxetine, which helps delay ejaculation. Men with a low sperm count can generally use Super Vilitra if it has been prescribed by a healthcare professional, as the medication is not intended to treat infertility or increase sperm production.
Low sperm count affects fertility, while erectile dysfunction affects the ability to achieve or maintain an erection. These are separate conditions, although some men may experience both at the same time. Super Vilitra may improve sexual performance by helping men achieve firmer erections and better control over ejaculation, but it does not increase sperm count, improve sperm quality, or enhance fertility.
Before taking Super Vilitra, men with fertility concerns should undergo a proper medical evaluation to identify the underlying cause of their low sperm count. Hormonal imbalances, infections, varicocele, lifestyle factors, and certain medications may contribute to reduced sperm production.
Super Vilitra should only be used under medical supervision, especially in men with heart disease, liver or kidney disorders, or those taking nitrate medications. A healthcare provider can determine whether the medication is appropriate and recommend additional treatments if fertility is the primary concern.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply